MSH3 and colorectal cancer: For instance, in the study by Meessen et al., in sporadic colorectal cancer in tumors with one to two markers positive for EMAST, downregulation of MSH3 mRNA was not detected, while in tumors with three to five markers positive for EMAST (which often coincides with MSI-H), MSH3 mRNA expression was downregulated [69].